HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA: Current REACH Registrations Could Fail New Completeness Check Coming In April

Executive Summary

The European Chemicals Agency will implement an updated completeness check process in April for dossiers submitted under REACH. The revised check will extend to chemical safety reports, the agency says, noting that dossiers previously submitted successfully may not pass muster now.

You may also be interested in...



COVID-19 Beauty News In Brief: Ulta Announces Furloughs; ECHA Postpones New Dossier Checks; More

Quick looks at how beauty and personal-care industry stakeholders are responding to the pandemic, from temporary furloughs to corporate citizenship investments and regulatory accommodations for beleaguered businesses.

ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

Cruelty Free International Seeks ‘More Humane’ REACH With Phase-In Registrations Now Wrapped

The NGO unveiled a six-point plan in July to reduce animal suffering under the European chemical regulation. Needs include greater funding to advance alternative methods and less red tape to encumber their regulatory approval, according to the animal-welfare group.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel